In a child’s mind, all dreams are within reach. We share the same boundless aspirations for our patients. For more than 25 years, we have been supporting the needs of patients and the growth hormone community. And we will continue to raise our expectations to meet patients' needs.




What is growth hormone deficiency (GHD)?

GHD is a rare disorder in which there is not enough secretion of growth hormone from the anterior pituitary gland. This disorder is estimated to affect 1 in 4,000 to 1 in 10,000 children.

GHD-graphic pit-mob

There are 3 types of GHD:

Congenital GHD

which is present from birth

Acquired GHD

which can be caused by trauma, infection, radiation therapy, or brain tumors

Idiopathic GHD

where no known cause can be

Continuing to build on a history of leadership in GHD care

For more than 25 years, Pfizer has been dedicated to developing treatments, advancing research, and supporting patients with GHD. Our long-standing commitment to the growth hormone community has helped tens of thousands of patients with a variety of growth disorders reach their treatment goals.

25years 25years-mobile
orange-arrowbar pink-arrowbar purple-arrowbar cyan-arrowbar

Demanding more for patients, caregivers, and the growth hormone community

At Pfizer, our dedication to the growth hormone community has always been focused on addressing the needs of patients and caregivers. We are committed to delivering quality treatment options that are both efficacious and safe.

Over the past 25 years, we have developed different formulations and devices for a variety of patients.

Moving forward, we will seek innovative ways to optimize the treatment of growth disorders without compromising the efficacy and safety that patients and their families have come to trust.


Raising awareness to help overcome gender disparities in diagnosis

Historical trends have shown that boys tend to be diagnosed with GHD twice as often as girls. The underdiagnosis of girls may reflect the belief in many societies that it is acceptable for girls to be short or “petite.”


To ensure that all appropriate patients have
an equal chance to receive the growth hormone
treatment they need, Pfizer is committed to raising
awareness about this diagnostic gender disparity.


As a parent who has had to give numerous shots over the last 12 years, the easier you make it, the better it is all the way around.


Quote heard in market research.

Addressing the evolving needs of patients and their families

Pfizer understands the impact that GHD can have on the lives of patients and caregivers. We recognize that patients can have individual treatment needs and preferences through different phases in life. That's why we remain devoted to exploring ways to better address the evolving needs of patients and caregivers, and support the health care professionals who treat them every day.


Trusted support and strength in numbers

We know nobody can do it all alone. Pfizer recognizes how valuable it is to be supported with the right information and connected to others in the growth hormone community, particularly for those coming to terms with a new diagnosis. Here are just a few of the many nonprofit patient assistance groups that you may find helpful.

These websites are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of these sites.

learn-banner Banner7-mob

Learn more about Pfizer's aspirations for patients with growth hormone disorders and other rare diseases